Bone targeted nano-drug and nano-delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Orthopedics

Background:

• Current treatments for bone disorders lack targeted delivery, leading to short drug half-lives and severe side effects.
• Nanotechnology, specifically nanoparticles (nano-drugs), shows promise for targeted drug delivery to diseased bone tissue.
• Developing bone-targeting nanoparticles is a key research area for treating bone diseases and repurposing therapies.

Purpose of the Study:

• To review the latest advancements in nanoparticle-based drug delivery systems for bone-related disorders.
• To focus on calcium-based nanoparticle systems and bisphosphonates for bone-targeted therapy.
• To provide a future perspective on developing safe and effective nano-therapies for bone diseases.

Main Methods:

• Review of current literature on nanotechnology applications in bone disease treatment.
• Focus on calcium-based nanoparticles modulating bone microenvironment.
• Analysis of bisphosphonates as nano-drugs and delivery systems.

Main Results:

• Nanoparticles can be designed for targeted delivery to bone, improving drug efficacy.
• Calcium-based nanoparticles show potential in modulating bone metabolism for disease inhibition.
• Bisphosphonates, when nano-formulated, offer enhanced bone targeting and controlled release.

Conclusions:

• Nanoparticle-based drug delivery systems represent a promising approach for treating bone disorders.
• Targeted delivery and controlled release of therapeutics at disease sites can lead to safer and more effective treatments.
• Future research in nano-drug development holds significant potential for managing bone diseases, including cancer metastasis.